SunWay Biotech and Gnosis by Lesaffre has announced a strategic partnership to launch their inaugural product, MenaQ7® Metabolic, featuring the ANKASCIN® 568-R.
Bora Pharmaceuticals Co., Ltd. (“Bora” or “the Company”, TWSE: 6472), today announced that its Board of Directors has approved the acquisition of Upsher-Smith Laboratories, Inc. (“Upsher-Smith”), a generics manufacturer based in Minnesota, US, from shareholders, Sawai Group Holdings Co., Ltd. (JP), and Sumitomo Corporation of Americas, for a total consideration of up to US$210 million.
Taipei, Taiwan – December 11, 2023 – Last Friday, Bora Pharmaceuticals officially embraced SunWay Biotech into the Bora family.
Bora Pharmaceuticals honored at the “2023 Most Outstanding Company of the Year Awards” ceremony with Taiwan’s President Tsai Ing-wen.